The Use of Indomethacin for Nocturnal Enuresis in Children With Nephrogenic Diabetes Insipidus: A Case Report and Review of the Literature.
Erin HedinAbdullah AlabbasPublished in: Canadian journal of kidney health and disease (2022)
Nocturnal enuresis is a bothersome symptom of NDI with adverse psychological effects. Indomethacin can improve nocturnal enuresis in some patients. Treatment with nonsteroidal anti-inflammatory drugs carries a risk of gastrointestinal and kidney side effects. We advocate for a patient-centered approach to the treatment of NDI which includes optimizing both the medical and the psychological needs of the patient.
Keyphrases
- blood pressure
- sleep quality
- obstructive sleep apnea
- end stage renal disease
- type diabetes
- chronic kidney disease
- ejection fraction
- cardiovascular disease
- healthcare
- anti inflammatory drugs
- newly diagnosed
- sleep apnea
- young adults
- prognostic factors
- emergency department
- depressive symptoms
- case report
- adipose tissue
- physical activity
- insulin resistance
- patient reported
- adverse drug